Stoke Therapeutics | 4:持股变动声明-高管 Kaye Edward M. MD
Stoke Therapeutics | 4:持股变动声明-股东 Skorpios Trust
Stoke Therapeutics | 4:持股变动声明-高管 Ticho Barry
Stoke Therapeutics | 4:持股变动声明-高管 Allan Jonathan
Stoke Therapeutics | 4:持股变动声明-高管 Kaye Edward M. MD
Stoke Therapeutics | 4:持股变动声明-高管 Ticho Barry
Stoke Therapeutics | 4:持股变动声明-高管 Allan Jonathan
Stoke Therapeutics | 4:持股变动声明-高管 Kaye Edward M. MD
Stoke Therapeutics | 4/A:持股变动声明(修正)-高管 Kaye Edward M. MD
Stoke Therapeutics | 4:持股变动声明-高管 Allan Jonathan
Stoke Therapeutics | 4:持股变动声明-高管 Kaye Edward M. MD
Stoke Therapeutics | 4:持股变动声明-高管 Ticho Barry
Stoke Therapeutics | 4:持股变动声明-高管 Kaye Edward M. MD
Stoke Therapeutics | 4:持股变动声明-高管 Allan Jonathan
Stoke Therapeutics | 4:持股变动声明-高管 Ticho Barry
Stoke Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Redmile Group, LLC(9.0%),Jeremy C. Green(9.0%)等
Stoke Therapeutics | SC 13G:超过5%持股股东披露文件-Baker Bros. Advisors LP(8.3%),Baker Bros. Advisors (GP) LLC(8.3%)等
Stoke Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Lynx1 Capital Management LP(9.9%),Weston Nichols(9.9%)
Stoke Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.24%)
Stoke Therapeutics | 4:持股变动声明-高管 Ticho Barry